The rising incidence rate of chronic diseases and the increasing number of geriatric population have resulted in boosting the Infusion Therapy market.
The Global Infusion therapy market is forecast to reach USD 10.98 Billion by 2027, according to a new report by Reports and Data. Infusion therapy is used to give antibiotics, and life-saving hydration fluids that are administered with the help of IV to care users. In this therapy, the medication is administered with the help of a catheter or a needle. Care providers recommend this therapy when the condition of the patient is severe, unable to swallow, or drug recommended is a biologic response. It is commonly used in hospitals; however, in the present healthcare scenario, it can be administered in outpatient infusion therapy centers or even at home care with the assistance of specially trained nurses. The therapy is usually employed for treating chronic infections or serious conditions when patients do not respond to oral antibiotics. Various initiatives of market players like, acquisition are also supporting the market growth. As an instance, in 2016, ICU Medical Inc. was supposed to acquire Pfizer Inc’s Hospira Infusion Systems Business for USD 1.00 Billion. Such initiatives by market players, along with strengthening their market position, are also propelling the market growth. In regards to the region, Europe is projected to occupy a considerable share of the market. The market share held by the region is attributed to the continuously expanding healthcare sector and rising geriatric population.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2601
Further key findings from the report suggest
- The Infusion therapy market held a market share of USD 7.61 Billion in the year 2018 that is forecasted to grow at a rate of 4.1% during the forecast period.
- In context to Product Type, the Infusion pumps held the largest market share of more than 30.0% in 2018, with a CAGR of 4.2% during the forecast period. The market share held by this segment is attributed to its extensive application in the healthcare sector due to the advantage of delivering fluids in small as well as large amount and applicability in delivering medications like hormones, antibiotics, chemotherapy drugs, and nutrients.
- In context to Therapy Type, the Nutritional therapy segment held the largest market share of 23.0% in 2018, with a significant growth rate of 4.2% during the forecast period. The fact this therapy is most commonly and extensively used in treating dehydration with the help of an intravenous drip in the healthcare sector contributes to the market share held by this segment.
- In regards to End-user, the Hospital segment held the largest market share of 49.0% in 2018, with a CAGR of 4.2% during the forecast period. The market share held by the segment is attributed to the increasing demand for cardiovascular treatment and chemotherapy from this care providing organizations.
- In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 5.1% during the forecast, which is expected to hold 0% of the market by 2027.
The global Infusion Therapy market is extremely competitive and comprise various global and regional players. GlaxoSmithKline plc, Johnson Johnson, Pfizer Inc. Allergan, Plc., AbbVie Inc., Fresenius SE Co. KGaA, B. Braun Melsungen AG., Takeda Pharmaceutical Company Limited., Baxter International Inc., Shire Plc and BioScrip. are some of the key players operating in the global market. These market players are various strategies such as mergers and acquisitions, collaborations, joint ventures, collaborations, partnerships and research and development investments to strengthen their market position and expand their product base.
Request a discount on the report @ https://www.reportsanddata.com/report-pricing/2601
For the purpose of this report, Reports and Data has segmented the global Infusion Therapy market on the basis of type, application and region:
Infusion Therapy Market segmentation by Types:
Disease Type Outlook (Revenue, USD Billion; 2016-2027)
- Cardiovascular diseases
- Cancer
- Infectious disease
- Diabetes
- Nephrology urological disorder
- Inflammatory diseases
- Pain management
- Immune deficiency disorders
- Others
Therapy Type Outlook (Revenue, USD Billion; 2016-2027)
- Inotropic therapy
- Antibiotic viral infusion therapy
- Chemotherapy
- Anti-coagulation infusion therapy
- Anesthesia
- Nutritional therapy
- Blood and blood component infusion therapy
- Others
Product Type Outlook (Revenue, USD Billion; 2016-2027)
- Intravenous sets
- Infusion pumps
- Needleless connectors
- IV cannulas
- Vein imaging devices
- Others
End-user Outlook (Revenue, USD Billion; 2016-2027)
- Hospital
- Clinics
- Ambulatory surgery centers
- Home care
- Others
Regional Outlook of Infusion Therapy Market:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
- Latin America (Brazil, Rest of LATAM)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2601
Thank you for reading our research report. Kindly contact us to know more about the customization feature and plans and out team will help you with the best suited report as per your requirement.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
